Trademark: 87701309
Status Date
Monday, June 24, 2019
Filing Date
Wednesday, November 29, 2017
Published for Opposition
Tuesday, March 27, 2018
Abandoned Date
Monday, June 24, 2019
5 Medicines for the treatment of refractory epilepsy, epilepsy, autism, anxiety
42 Pharmaceutical research and development; scientific and medical research
Oct 11, 2022
Teas Change Of Correspondence Received
Oct 11, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 11, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 24, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 24, 2019
Abandonment - No Use Statement Filed
Nov 23, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 21, 2018
Sou Extension 1 Granted
Nov 21, 2018
Sou Extension 1 Filed
Nov 21, 2018
Teas Extension Received
May 22, 2018
Noa E-Mailed - Sou Required From Applicant
Mar 27, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 27, 2018
Published For Opposition
Mar 7, 2018
Notification Of Notice Of Publication E-Mailed
Feb 16, 2018
Assigned To Lie
Feb 1, 2018
Approved For Pub - Principal Register
Jan 26, 2018
Examiner's Amendment Entered
Jan 26, 2018
Notification Of Examiners Amendment E-Mailed
Jan 26, 2018
Examiners Amendment E-Mailed
Jan 26, 2018
Examiners Amendment -Written
Jan 24, 2018
Assigned To Examiner
Dec 9, 2017
New Application Office Supplied Data Entered In Tram
Dec 2, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
